OneAscent Financial Services’s Royalty Pharma RPRX Stock Holding History

OneAscent Financial Services’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$272K	Sell	4,855 -1,924	-28%	-$100K	0.01%	513
2026 Q1	$325K	Buy	6,779 +811	+14%	+$35.5K	0.02%	438
2025 Q4	$231K	Buy	+5,968	New	+$228K	0.02%	411
2024 Q4	–	Sell	-7,357	Closed	-$208K	–	474
2024 Q3	$208K	Sell	7,357 -3,881	-35%	-$107K	0.15%	170
2024 Q2	$296K	Buy	11,238 +3,139	+39%	+$87K	0.04%	192
2024 Q1	$246K	Sell	8,099 -139	-2%	-$4.1K	0.03%	323
2023 Q4	$231K	Buy	+8,238	New	+$226K	0.03%	317

Other funds holding RPRX

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

OneAscent Financial Services's RPRX Position: Q2 2026 in Review

OneAscent Financial Services reduced its Royalty Pharma (RPRX) stake by 28% in Q2 2026, selling an estimated $100K and leaving 4,855 shares worth $272K. The position accounts for 0.01% of the portfolio, ranked #513.

OneAscent Financial Services first reported a position in RPRX in Q4 2023 and has held it in 7 quarters since. The position peaked at $325K in Q1 2026. 645 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

OneAscent Financial Services held 4,855 shares of Royalty Pharma worth $272K as of Q2 2026.
OneAscent Financial Services sold 1,924 Royalty Pharma shares in Q2 2026, an estimated $100K.
Royalty Pharma made up 0.01% of OneAscent Financial Services's portfolio in Q2 2026, its #513 holding.
OneAscent Financial Services first reported a position in Royalty Pharma in Q4 2023 and has held it in 7 quarters since.
OneAscent Financial Services's Royalty Pharma position peaked at $325K in Q1 2026.
645 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on OneAscent Financial Services's 13F filing for Q2 2026, filed 11 Aug 2026.